ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : -24 مورد

Doses of selective serotonin reuptake inhibitors used in the treatment of obsessive-compulsive disorder in adults

Doses of selective serotonin reuptake inhibitors used in the treatment of obsessive-compulsive disorder in adults
SSRI Starting dose (mg/day)* Target dose (mg/day) Supratherapeutic doses (mg/day)Δ
Fluoxetine 20 80 >80 to 120
Sertraline 50 200 >200 to 400
Escitalopram 10 30 >30 to 60
Fluvoxamine 50 300 >300 to 450
Paroxetine 20 60 >60 to 100

For use in conjunction with UpToDate content on the treatment of obsessive-compulsive disorder in adults. We check an electrocardiogram for changes in QT interval in all individuals treated with escitalopram ≥30 mg/day and any SSRI at supratherapeutic doses.

NOTE: Citalopram is not recommended because proarrhythmic effects may occur at higher doses.

SSRI: selective serotonin reuptake inhibitor.

* A lower starting dose and slower titration are recommended in patients who are older (age >65 years) or medically compromised (eg, heart failure, kidney, or liver disease), or patients with panic disorder, medication anxiety, or known to be sensitive to drug side effects.

¶ We typically titrate at twice monthly intervals, as tolerated, to the target dose. However, the pace of titration depends on several factors (eg, side effects). If symptoms start improving at a lower dose, that dose can be tried for a longer time, and the target dose may not be needed.

Δ We gradually increase to supratherapeutic dose in patients who have not had an adequate response to a target dose of an SSRI. We proceed cautiously in older patients (age >65), if a supratherapeutic dose is needed. Refer to UpToDate for further discussion of supratherapeutic dosing, therapeutic trials, and adverse effects of SSRI medications.

◊ Due to cardiac conduction concerns, we do not use escitalopram in older individuals (age >65 years).
Graphic 141578 Version 5.0